Annovis Bio, Inc.
For the period ended Mar 16, 2026. Filed Mar 16, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Mar 16, 2026 · Filed Mar 16, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99 · Forward-Looking Statements
Forward-Looking Statements
****This press release contains forward-looking statements under the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. Actual results may differ due to various risks and uncertainties, including those outlined in the Company’s SEC filings under “Risk Factors” in its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update forward-looking statements except as required by law.
Contact Information:
Annovis Bio Inc.
101 Lindenwood Drive
Suite 225
Malvern, PA 19355
www.annovisbio.com
Investor Contact:
Alexander Morin, Ph.D.
Director, Strategic Communications
Annovis Bio
ir@annovisbio.com
(Tables to follow)
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.